Home › Hansa Medical develops second-generation IdeS molecules for repeat dosing
 

Keywords :   


Hansa Medical develops second-generation IdeS molecules for repeat dosing

2015-02-12 14:11:05| Appliances - Topix.net

Hansa Medical AB announced today that the company is developing a new generation of molecules based on IdeS that will allow repeat dosing and thereby broadening the therapeutic opportunities into more chronic disease areas. Since IdeS is a bacterial protein from Group A streptococcus the human immune system recognizes IdeS as foreign and reacts against the molecule.

Tags: medical repeat develops molecules

Category:Consumer Goods and Services

Latest from this category

All news
24.11Young people who refuse to work to lose benefits - minister
24.11'I was scammed out of 75k by Martin Lewis deepfake advert'
23.11'Trust and reserve judgement' on rebrand, says Jaguar
23.11UK wants to hire EU negotiator to 'reset' relations
23.11Sisters build global beauty brand from a garage
23.11Versace bag for 15: Why Christmas shoppers are choosing charity shops
23.11'We are being robbed': Homeowners feel trapped by rising fees
23.11'We are being robbed': Homeowners feel trapped by rising fees
Consumer Goods and Services »
25.11 SGY-PM910ZW
25.11Pioneer DJ DDJ-SP1 DJ
25.11Dr.STONE
25.11
25.1146 dvd
25.11 SONY 4 CUH-1100A
25.11 COMPLETE DVD-BOX6
25.11DAHON /(330mm8°)
More »